CN
Home
Home
About Us
About Us
Ark Overview
Our Team
Our History
Our Culture
Our Advisors
Research
Research
Pipeline
Pipeline
Media
Media
Ark News
Career
Career
Contact Us
Contact Us
Investor relations
Investor relations
Corporate Governance
Board Members
Announcements and Circulars
Stock Information
IR
Home
About Us
Ark Overview
Our Team
Our History
Our Culture
Our Advisors
Research
Pipeline
Media
Ark News
Career
Contact Us
Investor relations
Corporate Governance
Board Members
Announcements and Circulars
Stock Information
IR
Ark News
2023
2022
2021
2020
2019
2018
2020-01-08
Ark Biosciences to present at JPM Healthcare Conference in San Francisco
2019-04-11
Ark Biosciences Reports Successful Completion of Phase II Proof-of-Concept Clinical Trial of Ziresovir for Treatment of Infants Hospitalized with Respiratory Syncytial Virus (RSV) Infection
2018-11-01
Ark Biosciences Reports Significant Progress of Phase 2 Clinical Trial of Ziresovir for Treatment of Hospitalized Respiratory Syncytial Virus (RSV) Infected Patients
2018-11-01
2018-08-22
Ark Biosciences to Present Efficacy Data on Novel Ziresovir at an International Conference
2018-08-22
Prev
1
2
Next
TOP
Home
Tel
Top
TOP
Telephone：
Address：
E-mail：
CN
